Clinical trial
Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer
NCT00446290 · Asan Medical Center, Other · Completed
Key facts
| NCT number | NCT00446290 |
|---|---|
| Title | Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer |
| Official title | A Phase I Study of Docetaxel, Capecitabine and Oxaliplatin (DXO) in Patients With Advanced Stomach Cancer |
| Lead sponsor | Asan Medical Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Stomach Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel, Capecitabine and Oxaliplatin |
| Enrollment | 22 |
| Start date | Mar 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Mar 12, 2007 |
| Last update posted | Jan 18, 2020 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: